Drugs / AVT80
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06732804 | Feb 2025 → Jan 2026 | — | Alvotech Swiss AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AVT80 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06732804 ↗ |
| Route | Subcutaneous | “Single subcutaneous injection of AVT80 (108mg)” NCT06732804 ↗ |